Literature DB >> 30150306

β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes.

Elad Horwitz1, Lars Krogvold2, Sophia Zhitomirsky1, Avital Swisa1, Maya Fischman1, Tsuria Lax1, Tehila Dahan1, Noa Hurvitz1, Noa Weinberg-Corem1, Agnes Klochendler1, Alvin C Powers3,4, Marcela Brissova3, Anne Jörns5, Sigurd Lenzen5,6, Benjamin Glaser7, Knut Dahl-Jørgensen2, Yuval Dor8.   

Abstract

Type 1 diabetes (T1D) is an autoimmune disease where pancreatic β-cells are destroyed by islet-infiltrating T cells. Although a role for β-cell defects has been suspected, β-cell abnormalities are difficult to demonstrate. We show a β-cell DNA damage response (DDR), presented by activation of the 53BP1 protein and accumulation of p53, in biopsy and autopsy material from patients with recently diagnosed T1D as well as a rat model of human T1D. The β-cell DDR is more frequent in islets infiltrated by CD45+ immune cells, suggesting a link to islet inflammation. The β-cell toxin streptozotocin (STZ) elicits DDR in islets, both in vivo and ex vivo, and causes elevation of the proinflammatory molecules IL-1β and Cxcl10. β-Cell-specific inactivation of the master DNA repair gene ataxia telangiectasia mutated (ATM) in STZ-treated mice decreases the expression of proinflammatory cytokines in islets and attenuates the development of hyperglycemia. Together, these data suggest that β-cell DDR is an early event in T1D, possibly contributing to autoimmunity.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2018        PMID: 30150306      PMCID: PMC6198335          DOI: 10.2337/db17-1006

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  49 in total

1.  Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells.

Authors:  Sharona Tornovsky-Babeay; Daniela Dadon; Oren Ziv; Elhanan Tzipilevich; Tehila Kadosh; Rachel Schyr-Ben Haroush; Ayat Hija; Miri Stolovich-Rain; Judith Furth-Lavi; Zvi Granot; Shay Porat; Louis H Philipson; Kevan C Herold; Tricia R Bhatti; Charles Stanley; Frances M Ashcroft; Peter In't Veld; Ann Saada; Mark A Magnuson; Benjamin Glaser; Yuval Dor
Journal:  Cell Metab       Date:  2013-12-12       Impact factor: 27.287

2.  Control of pancreatic β cell regeneration by glucose metabolism.

Authors:  Shay Porat; Noa Weinberg-Corem; Sharona Tornovsky-Babaey; Rachel Schyr-Ben-Haroush; Ayat Hija; Miri Stolovich-Rain; Daniela Dadon; Zvi Granot; Vered Ben-Hur; Peter White; Christophe A Girard; Rotem Karni; Klaus H Kaestner; Frances M Ashcroft; Mark A Magnuson; Ann Saada; Joseph Grimsby; Benjamin Glaser; Yuval Dor
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

Review 3.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

4.  β Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance.

Authors:  Cristina Aguayo-Mazzucato; Mark van Haaren; Magdalena Mruk; Terence B Lee; Caitlin Crawford; Jennifer Hollister-Lock; Brooke A Sullivan; James W Johnson; Aref Ebrahimi; Jonathan M Dreyfuss; Jan Van Deursen; Gordon C Weir; Susan Bonner-Weir
Journal:  Cell Metab       Date:  2017-04-04       Impact factor: 27.287

5.  Granzyme A, which causes single-stranded DNA damage, targets the double-strand break repair protein Ku70.

Authors:  Pengcheng Zhu; Dong Zhang; Dipanjan Chowdhury; Denis Martinvalet; Dennis Keefe; Lianfa Shi; Judy Lieberman
Journal:  EMBO Rep       Date:  2006-01-20       Impact factor: 8.807

6.  Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro: Results From the DiViD Study.

Authors:  Lars Krogvold; Oskar Skog; Görel Sundström; Bjørn Edwin; Trond Buanes; Kristian F Hanssen; Johnny Ludvigsson; Manfred Grabherr; Olle Korsgren; Knut Dahl-Jørgensen
Journal:  Diabetes       Date:  2015-02-12       Impact factor: 9.461

Review 7.  IP-10 and type 1 diabetes: a question of time and location.

Authors:  Urs Christen; Matthias G von Herrath
Journal:  Autoimmunity       Date:  2004-06       Impact factor: 2.815

8.  Diabetes mellitus, exocrine pancreatic deficiency, hypertrichosis, hyperpigmentation, and chronic inflammation: confirmation of a syndrome.

Authors:  Khalid Hussain; Raja Padidela; Ritika R Kapoor; Chela James; Kausik Banerjee; John Harper; Louise C Wilson; Raoul C M Hennekam
Journal:  Pediatr Diabetes       Date:  2008-10-22       Impact factor: 4.866

Review 9.  CXCR3, CXCL10 and type 1 diabetes.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Alda Corrado; Ele Ferrannini; Poupak Fallahi
Journal:  Cytokine Growth Factor Rev       Date:  2014-01-28       Impact factor: 7.638

10.  The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.

Authors:  Jon G Mabley; Gary J Southan; Andrew L Salzman; Csaba Szabó
Journal:  Pancreas       Date:  2004-03       Impact factor: 3.327

View more
  13 in total

1.  Cutting Edge: ST8Sia6-Generated α-2,8-Disialic Acids Mitigate Hyperglycemia in Multiple Low-Dose Streptozotocin-Induced Diabetes.

Authors:  Paul J Belmonte; Michael J Shapiro; Matthew J Rajcula; Shaylene A McCue; Virginia Smith Shapiro
Journal:  J Immunol       Date:  2020-04-29       Impact factor: 5.422

2.  DNA damage to β cells in culture recapitulates features of senescent β cells that accumulate in type 1 diabetes.

Authors:  Gabriel Brawerman; Jasmine Pipella; Peter J Thompson
Journal:  Mol Metab       Date:  2022-06-02       Impact factor: 8.568

3.  Unique Human and Mouse β-Cell Senescence-Associated Secretory Phenotype (SASP) Reveal Conserved Signaling Pathways and Heterogeneous Factors.

Authors:  Ayush Midha; Hui Pan; Cristian Abarca; Joshua Andle; Priscila Carapeto; Susan Bonner-Weir; Cristina Aguayo-Mazzucato
Journal:  Diabetes       Date:  2021-03-05       Impact factor: 9.461

4.  Impact of coxsackievirus-B4E2 combined with a single low dose of streptozotocin on pancreas of outbred mice: investigation of viral load, pathology and inflammation.

Authors:  Mehdi A Benkahla; Famara Sane; Antoine Bertin; Anais-Camille Vreulx; Firas Elmastour; Hela Jaidane; Rachel Desailloud; Didier Hober
Journal:  Sci Rep       Date:  2019-07-12       Impact factor: 4.379

5.  Increased double strand breaks in diabetic β-cells with a p21 response that limits apoptosis.

Authors:  Vanessa S Y Tay; Surabhi Devaraj; Tracy Koh; Guo Ke; Karen C Crasta; Yusuf Ali
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

6.  MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment.

Authors:  Shan Wan; Jie Zhang; Xiang Chen; Jiangli Lang; Li Li; Fei Chen; Li Tian; Yang Meng; Xijie Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-23       Impact factor: 5.555

7.  Aging and stress induced β cell senescence and its implication in diabetes development.

Authors:  Na Li; Furong Liu; Ping Yang; Fei Xiong; Qilin Yu; Jinxiu Li; Zhiguang Zhou; Shu Zhang; Cong-Yi Wang
Journal:  Aging (Albany NY)       Date:  2019-11-13       Impact factor: 5.682

Review 8.  Means, Motive, and Opportunity: Do Non-Islet-Reactive Infiltrating T Cells Contribute to Autoimmunity in Type 1 Diabetes?

Authors:  Teresa Rodriguez-Calvo; Gustaf Christoffersson; Christine Bender; Matthias G von Herrath; Roberto Mallone; Sally C Kent; Eddie A James
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 8.786

9.  Beta cell identity changes with mild hyperglycemia: Implications for function, growth, and vulnerability.

Authors:  Aref G Ebrahimi; Jennifer Hollister-Lock; Brooke A Sullivan; Ryohei Tsuchida; Susan Bonner-Weir; Gordon C Weir
Journal:  Mol Metab       Date:  2020-02-14       Impact factor: 7.422

Review 10.  Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells.

Authors:  Ewa Gurgul-Convey
Journal:  Cells       Date:  2020-08-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.